Topical Dexamethasone/Diclofenac Hydrogel for Postoperative Pain and Swelling in Facial Soft Tissue Injuries
Sponsor: Thamar University • ClinicalTrials.gov ID: NCT07853664
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This randomized, controlled clinical trial will evaluate the clinical effects of a topical thermoresponsive hydrogel containing dexamethasone sodium phosphate and diclofenac sodium on postoperative pain and facial swelling in patients undergoing extraoral maxillofacial surgical procedures or primary closure of clean facial soft tissue wounds. Participants will be stratified according to fracture status and randomly assigned to receive either the active hydrogel or an identical placebo hydrogel. Pain, facial swelling, wound healing, adverse events, patient satisfaction, and rescue analgesic consumption will be evaluated during the postoperative period.
Interventions
-
Poloxmer F-127 Hydrogel with Dexamethasone/Diclofenac
(Drug)
Active topical hydrogel formulation containing dexamethasone and diclofenac for pain and edema control.
-
Plain Pluronic F-127 Hydrogel Placebo
(Other)
Blank hydrogel vehicle without active pharmacologic agents.
Eligibility criteria
Conditions
Locations
- Alwehdah University Teaching Hospital — Dhamar, Yemen
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record